As of 2024-12-15, the Intrinsic Value of Clinigen Group PLC (CLIN.L) is
559.41 GBP. This CLIN.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 925.00 GBP, the upside of Clinigen Group PLC is
-39.50%.
The range of the Intrinsic Value is 387.36 - 888.89 GBP
559.41 GBP
Intrinsic Value
CLIN.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
387.36 - 888.89 |
559.41 |
-39.5% |
| DCF (Growth 10y) |
684.33 - 1,380.87 |
924.83 |
-0.0% |
| DCF (EBITDA 5y) |
653.11 - 1,971.94 |
1,181.97 |
27.8% |
| DCF (EBITDA 10y) |
873.31 - 2,372.93 |
1,459.12 |
57.7% |
| Fair Value |
464.51 - 464.51 |
464.51 |
-49.78% |
| P/E |
1,107.06 - 2,289.86 |
1,656.03 |
79.0% |
| EV/EBITDA |
745.57 - 6,307.90 |
2,463.81 |
166.4% |
| EPV |
477.66 - 654.91 |
566.29 |
-38.8% |
| DDM - Stable |
412.18 - 953.67 |
682.93 |
-26.2% |
| DDM - Multi |
412.66 - 739.18 |
529.40 |
-42.8% |
CLIN.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,231.64 |
| Beta |
1.66 |
| Outstanding shares (mil) |
1.33 |
| Enterprise Value (mil) |
1,527.24 |
| Market risk premium |
5.34% |
| Cost of Equity |
9.92% |
| Cost of Debt |
4.26% |
| WACC |
8.05% |